General Information of Drug (ID: DMO6U80)

Drug Name
GSK2321138A
Indication
Disease Entry ICD 11 Status REF
Influenza virus infection 1E30-1E32 Phase 3 [1]
Cross-matching ID
TTD ID
D00JZD

References

1 ClinicalTrials.gov (NCT01439360) An Efficacy Study of GlaxoSmithKline (GSK) Biologicals' Candidate Influenza Vaccine GSK2321138A in Children. U.S. National Institutes of Health.